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Abstract
Objective— This study describes the timing and correlates of folic acid supplement intake among
pregnant women.
Study design— Data from 2518 women with estimated delivery dates from 1997 to 2000, collected
for the National Birth Defects Prevention Study, a population-based case-control study, were
analyzed. Multinomial logistic regression was used to identify correlates of supplement intake.
Results—Fifty-three percent of women began taking folic acid supplement during the
periconceptional period, 35% during early pregnancy, and 8% during late pregnancy (ie, 3 months
before through 1 month after conception, 2–3 months after conception, or more than 3 months after
conception, respectively). Women who did not take folic acid supplement periconccptionally tended
to be nonwhite, speak Spanish, have low education, be younger than 25 years old. be nulliparous,
smoke, have no previous miscarriage and no fertility treatments, begin prenatal care and become
aware of their pregnancy after the first trimester, have nonplanned pregnancies, and eat less breakfast
cereal.
Conclusion— This study identifies correlates of folic acid supplement intake, which may
contribute to the design of interventions to improve intake during early pregnancy.
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The Public Health Service and the Institute of Medicine recommend that women of child-
bearing age consume at least 400 μg/day of synthetic folic acid (FA),1,2 an amount that is
present in most multivitamin/ mineral supplements. The recommendation was originally
intended to prevent neural tube defects. FA also may prevent other birth defects,3–7 other
adverse reproductive outcomes,8 and chronic diseases.8 Taking FA-containing supplements
remains the most likely route of meeting the recommended intake level, even after considering
folate intake from fortified foods.9,10 By the end of pregnancy, most women are taking FA
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supplements,11 but in the first few weeks, before pregnancy is clinically evident, closer to one
third of women take supplements daily.4,11–14 Intake during early pregnancy is critical
because most birth defects occur during the first few weeks of pregnancy. For example, neural
tube closure is completed by day 28 after conception, or 6 weeks after the last menstrual period.
Information on patterns of FA supplement intake during pregnancy and correlates of this
behavior is critical to the design of effective interventions to improve intake. Few studies have
examined correlates of supplement intake during pregnancy in relatively large and diverse
study populations and included multivariable analysis.11,15,16 We are aware of only 1 study
that examined whether predictors of supplement intake varied as pregnancy progressed, and
its data are from births that occurred in 1988, before the issuance of major public health
recommendations regarding FA.11 This study describes the pattern of intake of FA
supplements among pregnant women and examines correlates of FA supplement intake,
comparing correlates of intake during the periconceptional period and later during pregnancy,
using recent data from a large, multistate, population-based, case-control study.
Material and methods
This study included data on deliveries that had estimated due dates from October 1997 to
December 2000 and were part of the National Birth Defects Prevention Study.17 This study
is an approved activity of the institutional review boards of the participating study centers and
the Centers for Disease Control and Prevention, Each study site randomly selected
approximately 100 nonmalformed, liveborn controls per study year from birth certificates
(Iowa, Massachusetts, and New Jersey) or birth hospitals (Arizona. California. Georgia, New
York, and Texas) to represent the population from which the subjects were derived. Live-born
infants with major malformations were ineligible as, controls. This analysis included data from
controls only. Maternal interviews were conducted using a standardized, computer-based
questionnaire, primarily by telephone, in English or Spanish. Interviews were conducted with
2594 control mothers, representing 71% of eligibles, on average 8.6 months after delivery. We
excluded 76 women who were missing data on supplement intake, leaving 2518 women for
analysis.
Exposures to many factors were assessed, relative to the woman's estimated date of conception,
which was derived by subtracting 266 days from the woman's expected due date (EDD). The
EDD was based on mother's self-report; if unknown, the EDD was estimated from information
in the medical record (less than 2% of subjects). A shortened version of the Willett Food
Frequency Questionnaire (FFQ) assessed frequency of intake of 58 food items during the year
before pregnancy.18 Separate, more detailed questions assessed intakes of breakfast cereals,
tea and coffee, sodas, and food supplements (ie, products that are sometimes mixed into drinks,
like protein powder) during the 3 months before pregnancy. The U.S. Department of
Agriculture version 16 nutrient database served, as the source of nutrient values.19 Final
nutrient values incorporate data from the FFQ, cereals, beverages, and food supplements
combined. The dietary data were treated as missing for 78 women with more than 1 missing
food item in the FFQ (n = 31) and/or average daily kilocalorie consumption less than 500 or
more than 5000 (n = 63).
Women were queried about their intake of vitamin and mineral dietary supplements during the
12 weeks before conception through the date of delivery. For each supplement product, they
reported start and stop dates and frequency of intake; women who did not know the exact start
or stop date of intake reported duration of intake; this information was receded to correspond
to month-long (ie, 30-day) increments before or after the date of conception. All products were
hand reviewed to assess whether they contained FA. Women were divided into four groups:
(1) periconceptional intake, in which intake began during the 3 months before conception (or
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earlier) or during the first month after conception; (2) early pregnancy intake, in which intake
began during the second or third month after conception; (3) late intake, in which intake began
during the fourth month or later during pregnancy; or (4) no intake during the 3 months before
conception or during pregnancy. Within these groups, we identified women as having
continuous or sporadic intake (ie, intake was continued until delivery or was discontinued
before delivery).
Potential correlates of supplement intake included mother's race-ethnicity; nativity; language
of interview; education; household income; employment during the 3 months before
conception through the time of delivery; age; prepregnancy body mass index; number of
previous live births; previous miscarriage; fertility treatments (based on a positive response to
any of the following three questions: "Did you have any surgical procedures... [to help you
become pregnant]?"; "in the 2 months before you became pregnant with [baby's name], did
you take any medications to help you become pregnant?"; or "did you have any other
procedures to help you become pregnant...?"); nausea or vomiting during the first trimester;
cigarette smoking, alcohol consumption, and recreational drug use during the 3 months before
conception through the time of delivery; trimester of first prenatal care visit; trimester when
pregnancy was recognized; pregnancy wantedness (defined below); daily intake of dietary
folate equivalents19; daily servings of ready-to-cat breakfast cereal; daily servings of fruits
and vegetables (to reflect diet quality): and study site. Pregnancy wantedness was categorized
as: (1) wanted to become pregnant then, (2) wanted to wait until later, (3) did not want to
become pregnant at all, (4) no preference, and (5) became pregnant while using contraception
consistently. The first 4 categories were taken directly from a question about pregnancy
wantedness. The final category was derived from a question about use of contraception because
women who became pregnant while using contraception were not asked about pregnancy
wantedness.
We examined correlates of FA supplement intake during each defined time period. We
estimated odds ratios (ORs) and 95% confidence intervals (CIs) from multinomial logistic
regression models in SAS using PROC CATMOD (version 9.1, 2002-2003, SAS Institute,
Cary, NC). Periconceptional users served as the reference group for all comparisons because
they represent the ideal behavior. We first put all potential covariates into a single model and
excluded 1 variable at a time, based on the highest P value, until all variables in the model had
P values less than .20. The overall P values reflect whether any of the groups being compared
differed from periconceptional users. Multivariable analyses were conducted separately for
women with continuous and sporadic intake.
Results
Among the 2518 women interviewed, 53% (1324) began taking FA supplements before or
during the periconceptional period, 35% (879) during early pregnancy, and 8% (208) during
late pregnancy, such that overall, 96% (2411) took FA supplements at some time during the 3
months before pregnancy or during pregnancy (Table I), Two percent of the women (39) took
only non-FA-containing supplements, and 3% (68) took no supplements during this time
period. Among women who took FA supplements, 94% (2256) reported daily intake, 97%
(2346) reported intake of prenatal multivitamin/mineral formulations, and 84% (2021)
continued intake through delivery.
The main multivariable analysis included 1948 women with continuous (ie, nonsporadic) FA
intake or no supplement intake. Table II shows the distribution of each of the variables included
in the final multivariable model, within each of the 4 supplement use groups. Table III shows
the adjusted ORs associated with each variable, and each supplement use group, relative to
periconceptional users. The following variables were not predictive of periconceptional FA
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intake (overall P values of .20 or greater): maternal nativity, income, employment, body mass
index, nausea during the first trimester, pregnancy wantedness, dietary folate intake, and daily
servings of fruits and vegetables.
Relative to non-Hispanic white women, who were more likely to be periconceptional
supplement users than women in other racial-ethnic groups, women with other race-ethnicities
were about 2 times more likely to begin taking FA supplements during early pregnancy than
they were to take supplements during the periconceptional period. Relative to non-Hispanic
white women, they tended to be even more likely to begin supplement intake later during
pregnancy or not at all (ORs ranged from 2.0 to 5.0). A similar pattern was observed for women
with less than 4 years of college. Women interviewed in Spanish were at increased risk of
nonpericonceptional supplement intake (OR range 2.0 to 7.2), compared with women
interviewed in English, Women younger than 20 years old were more likely to begin FA intake
after the periconceptional period or not at all (OR range 2.3 to 2.9).
Women who had 2 or more previous live births were at increased risk of no intake (OR 3.1,
95% CI 1.3 to 7.0), The ORs among women who had any fertility treatments ranged from 0,2
to 0.4, suggesting that they were 2.5 to 5.0 times more likely to be periconceptional users.
Relative to women who began prenatal care in the first trimester, women who began care in
the second trimester were at increased risk of nonpericonceptional intake (OR range 1.5 to
24.9). Results were mixed for women who began prenatal care in the third trimester or not at
all, probably because of the small number of women in this category. Women who became
aware of their pregnancy after the first trimester were more likely to report late or no supplement
intake than periconceptional intake (OR range 1.3 to 9.3).
In general, the factors that were associated with early pregnancy FA intake had even stronger
associations with late pregnancy intake. Associations with no intake were less consistent,
perhaps due to the small number of women who did not take any FA supplements.
Among the 390 women with sporadic patterns of intake, 50% (195) began taking supplements
in the periconceptional period, 38% (149) in early pregnancy, and 12% (46) in late pregnancy.
Most of them (67%) stopped taking supplements during late pregnancy. Multinomial logistic
regression results were similar as for women with continuous FA intake, with 1 exception: the
addition of pregnancy wantedness (data not shown). Women who were not trying to get
pregnant tended to be more likely to be nonpericonceptional users, with most of the estimated
ORs around 1.5.
Comment
This study indicates that most (96%) women from several regions of the United States took
FA supplements during pregnancy. However, only 53% took FA around the time of neural
tube closure, which is completed by 4 weeks after conception.
Women who were not taking FA supplements during the first few weeks after conception (ie,
the periconceptional period) tended to be nonwhite and younger than 25 years old, have low
education, begin prenatal care and become aware of their pregnancy after the first trimester,
and have nonplanned pregnancies, findings that parallel several previous studies. 11,12,15,
16,20–22 Women who had fertility treatments were much more likely to take FA supplements
around the time of conception than women who did not have any treatments. Women who had
a previous live birth, especially women with 2 or more live births, had an increased risk of no
intake.
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Unique contributions of this study include its description of when women began taking FA
supplements by month of pregnancy, multivariable analysis of a wide variety of potential
correlates of supplement intake, and comparison of correlates among different groups of
women based on when they began taking FA. Additional advantages are that it includes a
recent, population-based, multistate sample, and data on supplement intake were detailed with
regard to timing and frequency and types of supplements taken. Nonetheless, our ability to
estimate the contribution of correlates may be compromised by certain study design features.
Individuals may have been misclassified with regard to type, timing, and frequency of
supplement intake. The validity of self-reported supplement intake is likely to be high,23,24
especially with regard to FA content, given the predominant intake of prenatal supplements,
which have relatively standard FA content. The extent of error in the reported dates of intake,
or in reported estimated dates of delivery, is unknown. The relatively small number of women
who did not take any FA-containing supplements limited the precision with which we could
estimate risks within this group. The potential impact of selection bias is unknown.
A recent study using data from the Pregnancy Risk Assessment Monitoring System reported
prevalences of FA supplement intake at least 4 times per week during the month before
pregnancy from 25% to 41% across 19 states.14 A recent case-control study, based on data
from Boston, Philadelphia, and Toronto, reported that 40% of women took FA supplements
daily during the 3 months before pregnancy and during the first trimester.16 These results
compare well with our finding that 31 % of women reported taking FA supplements before
conception. Participants in our study were similar to all women giving birth in the United States
in the year 2000 with regard to parity, age, and trimester of first prenatal care visit, and they
were somewhat more likely to be non-Hispanic white (65% versus 58%) and to have more than
12 years of education (61% versus 46%).25
Most women do not meet the recommended levels for FA intake by consuming foods,9,10 and
FA-containing supplements remain an important vehicle for meeting recommendations. Most
women in this study took FA supplements that contained various additional micronutrients,
which may further improve the likelihood of a healthy pregnancy outcome.
Some of the factors that characterized women who did not take FA supplements during the
periconceptional period are also associated with increased neural tube defect risk (eg, low
education, Hispanic race-ethnicity, and Spanish language preference).26,27 Recent
improvements in FA supplement intake seem to be smallest among some of these most
vulnerable groups, reiterating the need for interventions that focus on certain subgroups of the
population.28
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Table I
Distribution of intake of FA-containing supplements during the 3 months before conception through the time of
delivery*
Category of supplement use Percent (number)
Took no supplements 2.7 (68)
Took only non-FA-containing supplements 1.5 (39)
Took FA-containing supplements 95.8 (2411)
Total 100 (2518)
Among FA-containing supplement users, months before or after conception when supplement intake began
 During the 3 months before conception or earlier 31.3 (789)
 First month after conception 21.3 (535)
 Second month after conception 23.6 (594)
 Third month after conception 11.3 (285)
 Fourth month after conception 4.9 (122)
 Fifth month after conception 1.9 (48)
 Sixth month after conception 0.8 (20)
 Seventh month after conception 0.4 (11)
 Eighth month after conception 0.2 (6)
 Ninth or 10th month after conception < 0.1 (1)
 Total 95.8 (2411)
*
Among 2,518 women with estimated dates of delivery from October, 1997 to December, 2000.
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